Hepatitis E Virus Seroprevalence and Chronic Infections in Patients with HIV, Switzerland

Publication

Hepatitis E Virus Seroprevalence and Chronic Infections in Patients with HIV, Switzerland

Journal Paper/Review - Jun 1, 2011

Kenfak-Foguena Alain, Cavassini Matthais, Izpopet Jacques, Abravanel Florence, Moradpour Darius, Jost Josef, Gurter-De La Fuente Vanina, Elzi Luigia, Evison John-Marc, Kaiser Laurent, Kovari Helen, Darling Katharine E A, Witteck Andrea, Bürgisser Phillippe, Schöni-Affolter Franziska, Data Center of the Swiss HIV Cohort Study, Lausanne, Switzerland

Units

Division of Infectious Diseases, Infection Prevention and Travel Medicine

PubMed

21749774

Citation

Kenfak-Foguena A, Cavassini M, Izpopet J, Abravanel F, Moradpour D, Jost J, Gurter-De La Fuente V, Elzi L, Evison J, Kaiser L, Kovari H, Darling K, Witteck A, Bürgisser P, Schöni-Affolter F, Data Center of the Swiss HIV Cohort Study, Lausanne, Switzerland. Hepatitis E Virus Seroprevalence and Chronic Infections in Patients with HIV, Switzerland. Emerging Infect Dis 2011; 17:1074-8.

Type

Journal Paper/Review (English)

Journal

Emerging Infect Dis 2011; 17

Publication Date

Jun 1, 2011

Issn Electronic

1080-6059

Pages

1074-8

Brief description/objective

We screened 735 HIV-infected patients in Switzerland with unexplained alanine aminotransferase elevation for hepatitis E virus (HEV) immunoglobulin G. Although HEV seroprevalence in this population is low (2.6%), HEV RNA can persist in patients with low CD4 cell counts. Findings suggest chronic HEV infection should be considered as a cause of persistent alanine aminotransferase elevation.